Galectin Therapeutics to Present at Berenberg NASH Day in New York
25 févr. 2019 08h00 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H....
Galectin Therapeutics Announces Extension of $10 Million Line Credit
20 déc. 2018 08h30 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that its $10 million...